Rapid and sensitive detection of Nampt (PBEF/visfatin) in human serum using an ssDNA aptamer-based capacitive biosensor

Jee Woong Park, Sreenivasa Saravan Kallempudi, Javed H. Niazi, Yasar Gurbuz, Byung Soo Youn, Man Bock Gu

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

A single-stranded DNA (ssDNA) aptamer was successfully developed to specifically bind to nicotinamide phosphoribosyl transferase (Nampt) through systematic evolution of ligands by exponential enrichment (SELEX) and successfully implemented in a gold-interdigitated (GID) capacitor-based biosensor. Surface plasmon resonance (SPR) analysis of the aptamer revealed high specificity and affinity (Kd=72.52nM). Changes in surface capacitance/charge distribution or dielectric properties in the response of the GID capacitor surface covalently coupled to the aptamers in response to changes in applied AC frequency were measured as a sensing signal based on a specific interaction between the aptamers and Nampt. The limit of detection for Nampt was 1ng/ml with a dynamic serum detection range of up to 50ng/ml; this range includes the clinical requirement for both normal Nampt level, which is 15.8ng/ml, and Nampt level in type 2 diabetes mellitus (T2DM) patients, which is 31.9ng/ml. Additionally, the binding kinetics of aptamer-Nampt interactions on the capacitor surface showed that strong binding occurred with increasing frequency (range, 700MHz-1GHz) and that the dissociation constant of the aptamer under the applied frequency was improved 120-240 times (Kd=0.3-0.6nM) independent on frequency. This assay system is an alternative approach for clinical detection of Nampt with improved specificity and affinity.

Original languageEnglish
Pages (from-to)233-238
Number of pages6
JournalBiosensors and Bioelectronics
Volume38
Issue number1
DOIs
Publication statusPublished - 2012 Oct 1

Fingerprint

Nicotinamide Phosphoribosyltransferase
Nucleotide Aptamers
Niacinamide
Single-Stranded DNA
Biosensing Techniques
Transferases
Biosensors
DNA
Capacitors
Gold
Serum
Charge distribution
Surface plasmon resonance
Medical problems
Dielectric properties
Assays
Capacitance
Ligands
SELEX Aptamer Technique
Kinetics

Keywords

  • Aptamer
  • Capacitive biosensor
  • Nampt (PBEF/visfatin)
  • SELEX

ASJC Scopus subject areas

  • Biophysics
  • Biomedical Engineering
  • Biotechnology
  • Electrochemistry

Cite this

Rapid and sensitive detection of Nampt (PBEF/visfatin) in human serum using an ssDNA aptamer-based capacitive biosensor. / Park, Jee Woong; Saravan Kallempudi, Sreenivasa; Niazi, Javed H.; Gurbuz, Yasar; Youn, Byung Soo; Gu, Man Bock.

In: Biosensors and Bioelectronics, Vol. 38, No. 1, 01.10.2012, p. 233-238.

Research output: Contribution to journalArticle

Park, Jee Woong ; Saravan Kallempudi, Sreenivasa ; Niazi, Javed H. ; Gurbuz, Yasar ; Youn, Byung Soo ; Gu, Man Bock. / Rapid and sensitive detection of Nampt (PBEF/visfatin) in human serum using an ssDNA aptamer-based capacitive biosensor. In: Biosensors and Bioelectronics. 2012 ; Vol. 38, No. 1. pp. 233-238.
@article{a517878ecb0e4e11b3fb9ab8706e5cad,
title = "Rapid and sensitive detection of Nampt (PBEF/visfatin) in human serum using an ssDNA aptamer-based capacitive biosensor",
abstract = "A single-stranded DNA (ssDNA) aptamer was successfully developed to specifically bind to nicotinamide phosphoribosyl transferase (Nampt) through systematic evolution of ligands by exponential enrichment (SELEX) and successfully implemented in a gold-interdigitated (GID) capacitor-based biosensor. Surface plasmon resonance (SPR) analysis of the aptamer revealed high specificity and affinity (Kd=72.52nM). Changes in surface capacitance/charge distribution or dielectric properties in the response of the GID capacitor surface covalently coupled to the aptamers in response to changes in applied AC frequency were measured as a sensing signal based on a specific interaction between the aptamers and Nampt. The limit of detection for Nampt was 1ng/ml with a dynamic serum detection range of up to 50ng/ml; this range includes the clinical requirement for both normal Nampt level, which is 15.8ng/ml, and Nampt level in type 2 diabetes mellitus (T2DM) patients, which is 31.9ng/ml. Additionally, the binding kinetics of aptamer-Nampt interactions on the capacitor surface showed that strong binding occurred with increasing frequency (range, 700MHz-1GHz) and that the dissociation constant of the aptamer under the applied frequency was improved 120-240 times (Kd=0.3-0.6nM) independent on frequency. This assay system is an alternative approach for clinical detection of Nampt with improved specificity and affinity.",
keywords = "Aptamer, Capacitive biosensor, Nampt (PBEF/visfatin), SELEX",
author = "Park, {Jee Woong} and {Saravan Kallempudi}, Sreenivasa and Niazi, {Javed H.} and Yasar Gurbuz and Youn, {Byung Soo} and Gu, {Man Bock}",
year = "2012",
month = "10",
day = "1",
doi = "10.1016/j.bios.2012.05.036",
language = "English",
volume = "38",
pages = "233--238",
journal = "Biosensors",
issn = "0956-5663",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Rapid and sensitive detection of Nampt (PBEF/visfatin) in human serum using an ssDNA aptamer-based capacitive biosensor

AU - Park, Jee Woong

AU - Saravan Kallempudi, Sreenivasa

AU - Niazi, Javed H.

AU - Gurbuz, Yasar

AU - Youn, Byung Soo

AU - Gu, Man Bock

PY - 2012/10/1

Y1 - 2012/10/1

N2 - A single-stranded DNA (ssDNA) aptamer was successfully developed to specifically bind to nicotinamide phosphoribosyl transferase (Nampt) through systematic evolution of ligands by exponential enrichment (SELEX) and successfully implemented in a gold-interdigitated (GID) capacitor-based biosensor. Surface plasmon resonance (SPR) analysis of the aptamer revealed high specificity and affinity (Kd=72.52nM). Changes in surface capacitance/charge distribution or dielectric properties in the response of the GID capacitor surface covalently coupled to the aptamers in response to changes in applied AC frequency were measured as a sensing signal based on a specific interaction between the aptamers and Nampt. The limit of detection for Nampt was 1ng/ml with a dynamic serum detection range of up to 50ng/ml; this range includes the clinical requirement for both normal Nampt level, which is 15.8ng/ml, and Nampt level in type 2 diabetes mellitus (T2DM) patients, which is 31.9ng/ml. Additionally, the binding kinetics of aptamer-Nampt interactions on the capacitor surface showed that strong binding occurred with increasing frequency (range, 700MHz-1GHz) and that the dissociation constant of the aptamer under the applied frequency was improved 120-240 times (Kd=0.3-0.6nM) independent on frequency. This assay system is an alternative approach for clinical detection of Nampt with improved specificity and affinity.

AB - A single-stranded DNA (ssDNA) aptamer was successfully developed to specifically bind to nicotinamide phosphoribosyl transferase (Nampt) through systematic evolution of ligands by exponential enrichment (SELEX) and successfully implemented in a gold-interdigitated (GID) capacitor-based biosensor. Surface plasmon resonance (SPR) analysis of the aptamer revealed high specificity and affinity (Kd=72.52nM). Changes in surface capacitance/charge distribution or dielectric properties in the response of the GID capacitor surface covalently coupled to the aptamers in response to changes in applied AC frequency were measured as a sensing signal based on a specific interaction between the aptamers and Nampt. The limit of detection for Nampt was 1ng/ml with a dynamic serum detection range of up to 50ng/ml; this range includes the clinical requirement for both normal Nampt level, which is 15.8ng/ml, and Nampt level in type 2 diabetes mellitus (T2DM) patients, which is 31.9ng/ml. Additionally, the binding kinetics of aptamer-Nampt interactions on the capacitor surface showed that strong binding occurred with increasing frequency (range, 700MHz-1GHz) and that the dissociation constant of the aptamer under the applied frequency was improved 120-240 times (Kd=0.3-0.6nM) independent on frequency. This assay system is an alternative approach for clinical detection of Nampt with improved specificity and affinity.

KW - Aptamer

KW - Capacitive biosensor

KW - Nampt (PBEF/visfatin)

KW - SELEX

UR - http://www.scopus.com/inward/record.url?scp=84864393537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864393537&partnerID=8YFLogxK

U2 - 10.1016/j.bios.2012.05.036

DO - 10.1016/j.bios.2012.05.036

M3 - Article

VL - 38

SP - 233

EP - 238

JO - Biosensors

JF - Biosensors

SN - 0956-5663

IS - 1

ER -